Revenue
2021
2022
2023
2024
2025
Jin Medical International Ltd. (ZJYL)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $20.7M | $23.5M | $19.8M | $19.2M | $20.8M |
| Gross profit | $6.0M | $9.5M | $6.8M | $6.2M | $6.4M |
| Research & development | $1.6M | $1.5M | $1.5M | $1.9M | $1.6M |
| Operating expenses | $5.4M | $5.9M | $3.9M | $4.1M | $3.7M |
| Operating income | $608,182 | $3.6M | $2.9M | $2.1M | $2.6M |
| EBITDAderived | $851,585 | $3.9M | $3.1M | $2.5M | $3.0M |
| Net income | $1.2M | $3.7M | $2.9M | $2.7M | $2.6M |
| Basic EPSper diluted share | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| Diluted EPSper diluted share | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |